These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Methotrexate for rheumatoid arthritis patients who are on hemodialysis.
    Author: Al-Hasani H, Roussou E.
    Journal: Rheumatol Int; 2011 Dec; 31(12):1545-7. PubMed ID: 21833520.
    Abstract:
    Methotrexate (MTX) can be toxic to patients suffering from end stage renal disease (ESRD) on hemodialysis even at low doses. This increase in toxicity is more notable in terms of bone marrow suppression in the form of pancytopenia. Many methods of elimination including dialysis itself have been proven ineffective, and alternate treatments with anti-TNF alpha blockers can be considered.
    [Abstract] [Full Text] [Related] [New Search]